Grant McQuaker

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Rowena D. Faulkner, Charles Craddock, Prem Mahendra et al. · Blood · 2003 · 166 citations · Full text

Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation as Alternative to Matched Sibling or Unrelated Donor Transplantation for Hodgkin Lymphoma: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Carmen Martı́nez, Jorge Gayoso, Carmen Canals et al. · Journal of Clinical Oncology · 2017 · 159 citations

Donor Transplantation, Chronic Gvhd, Hodgkin Lymphoma +15

Role of Nonmyeloablative Allogeneic Stem-Cell Transplantation After Failure of Autologous Transplantation in Patients With Lymphoproliferative Malignancies

Katharine Branson, Rajesh Chopra, Panagiotis Kottaridis et al. · Journal of Clinical Oncology · 2002 · 119 citations

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

Wendy A. Stewart, Rachel Pearce, Keiren Kirkland et al. · Bone Marrow Transplantation · 2010 · 70 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +11

High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation

Gordon Cook, Simona Iacobelli, Anja van Biezen et al. · Haematologica · 2016 · 65 citations · Full text